• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Glaucoma

Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension

Status:	History
Publication date:	April 2009
Wave:	12
Process:	CG
Topic area: Eye Surgical procedures

Project team | Schedule | Project history | Key documents

 

NICE project team

Centre for clinical practice lead:	Andrew Dillon
Communications manager:	Adrian Ward
Guidelines commissioning manager:	Sarah Willett
Guidelines coordinator:	Andrew Gyton
Patient involvement lead:	Victoria Thomas
Lead collaborating centre:	Clinical Guidelines Centre for Acute and Chronic Conditions (NCGCACC)
Guidance developer contact:	Jennifer Hill
Guidelines Development Group:	The Guideline Development Group (GDG) oversees the development process.

Top

Email enquiries

If you have any queries please email nice@nice.org.uk

Top

 

Provisional schedule

Scoping workshop:	05 March 2007
Consultation on draft scope with stakeholders:	26 February - 26 March 2007
Consultation on draft guideline with stakeholders:	29 Sept 08 – 24 Nov 08
Pre-publication check:	TBC
Publication date:	April 2009

Top

 

Project history

Date Update 10 February 2006 The remit for this guideline was received from the Department of Health and the Welsh Assembly Government in November 2005 as part of the Institute's 12th wave work programme. See below for more information on the Institute's guideline development process. 26 February 2007 The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed above, by the deadline shown. 27 March 2007 Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply. 26 July 2007 The scope defines what aspects of care are covered by the guideline and to whom it applies. 26 February 2008 Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process. See a list of GDG members. The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It  will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG.  Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline.  Please see timescales for dates of consultation with stakeholders. 1 April 2009 Responsibility for the development of this guideline has transferred to the National Clinical Guidelines Centre for Acute and Chronic Conditions. Key contacts and timelines remain unchanged.

Top

 

Key documents

Glaucoma: draft guideline stakeholder comments 22 April 2009 Clinical Guidelines Centre for Acute and Chronic Conditions (NCGCACC) 01 April 2009 Glaucoma: list of stakeholders 14 April 2009 Glaucoma: guideline consultation 29 September 2008 GDG minutes 24 April 2008 Glaucoma: scope consultation comments table 12 September 2007 Glaucoma: final scope 11 July 2007 Glaucoma: list of guideline development group members 26 July 2007 Invitation to apply for membership of the guideline development group on glaucoma and ocular hypertension 22 March 2007 Patient/carer membership of the glaucoma guideline development group 16 March 2007 Glaucoma: draft scope, commments form 26 February 2007 The guideline development process - an overview for stakeholders, the public and the NHS (third edition) 25 April 2007 Glaucoma: draft scope 26 February 2007 Glaucoma: remit 23 February 2007 Stakeholder registration 21 April 2004 National Collaborating Centre for Acute Care 02 June 2003

This page was last updated: 30 March 2010